Terlipressin combined with Pranolol for influence of blood pressure and hemodynamic indexes in patients with upper gastrointestinal bleeding in liver cirrhosis
FAN Wen-jun1 WU Xia2▲
1. Department of Gastroenterology, Qianjiang Central Hospital, Hubei Province, Qianjiang 433100, China;
2. Department of Endoscopy Center, Qianjiang Central Hospital, Hubei Province, Qianjiang 433100, China
Abstract：Objective To analyze the effects of Terlipressin combined with Propranolol on blood pressure and hemodynamics indexes in patients with upper gastrointestinal bleeding (UGB) in liver cirrhosis. Methods The clinical data of 112 patients with UGB with liver cirrhosis in Qianjiang Central Hospital from February 2019 to February 2021 were retrospectively analyzed. They were divided into reference group and experimental group according to different treatment methods, 56 patients in the reference group were treated with propranolol, and 56 patients in the experimental group were treated Terlipressin combined with Pranolol treatment, the clinical efficacy, blood pressure and hemodynamics between the two groups were compared. Results The total clinical effective rate (96.43%) of the test group was higher than the reference group(75.00%),and the difference was statistically significant (P＜0.05).The systolic blood pressure ([130.62±5.31]ml/min) after treatment in the test group was higher than the reference group (119.26±2.05) ml/min,diastolic blood pressure ([90.52±5.13]ml/min) was higher than the control group ([78.26±4.27]ml/min), the differences were statistically significant (P＜0.05). The portal vein (PV) blood flow ([705.26±13.62]ml/min) of the experimental group after treatment was less than the control group([846.26±18.62]ml/min),the PV blood flow velocity of the test group([13.26±1.05]cm/min) was slower than the control group ([17.62±2.11]cm/min), and the PV inner diameter ([9.13±1.62]mm) was shorter than that of the reference group ([13.82±2.17]mm), the differences were statistically significant (P＜0.05). Conclusion Terlipressin combined with Pranolol can effectively reduce the amount of bleeding in UGB patients with liver cirrhosis and maintain hemodynamic stability.
范文俊；吴霞. 特利加压素联合普奈洛尔对肝硬化上消化道出血患者血压及血流动力学指标的影响[J]. 中国当代医药, 2021, 28(35): 54-56转60.
FAN Wen-jun1 WU Xia2▲. Terlipressin combined with Pranolol for influence of blood pressure and hemodynamic indexes in patients with upper gastrointestinal bleeding in liver cirrhosis. 中国当代医药, 2021, 28(35): 54-56转60.
京公网安备 11010502046607号